The link between the onset of major depressive disorder (MDD) and loss of neurotrophins in the brain is of interest to clinicians and basic scientists. MDD is caused by a combination of genetic, environmental, and psychological factors. Trauma, chronic health problems, and substance abuse are risks (1), as are grief and other purely emotional/cognitive stresses (2, 3). MDD alters the expression of neurotrophins, such as brain-derived neurotrophic factor (BDNF). BDNF is required for neuronal development, survival, and plasticity (4, 5). Brain imaging has shown volumetric changes in limbic regions in depression attributed either to reduced numbers of glia and pyramidal neurons or to their reduced cell body size, accompanied by atrophy of pyramidal neuron apical dendrites and decreases in neurogenesis in dentate gyrus (6). These structural alterations most likely contribute to features of depression, including cognitive impairment, helplessness, and anhedonia. Neuronal dysfunction also affects activation of the hypothalamic–pituitary–adrenal axis (7). Studies show that structural and functional neuronal alterations in MDD are partially rescued by antidepressant treatment. Antidepressants, in addition to their effects on neurotransmitter levels, also increase BDNF and enhance expression of the receptor for BDNF, tropomyosin-related kinase B (TrkB), in the hippocampus (8). However, the intracellular mechanisms governing the relationship between BDNF, structural changes in limbic system cells, and clinical manifestations of MDD are still unclear.
In PNAS, Marshall et al. (9) demonstrate that Gαi1 and Gαi3, members of the GαI subclass of heterotrimeric G proteins, are essential for BDNF/TrkB signaling in hippocampus and are down-regulated by chronic stress. G proteins form membrane-associated heterotrimers consisting of α, β, and γ subunits (10). There are four main subclasses: Gs, Gi/o, Gq, and G12/13. GαI belongs to the Gi/o subclass and inhibits adenylyl cyclase. Marshall et al. report that reductions in Gαi1 and Gαi3 levels affect BDNF-induced TrkB endocytosis and activation of signaling pathways downstream of TrkB, resulting in depressive behaviors. In mouse embryonic fibroblasts, they show that the double knockout (DKO) of Gαi1 and Gαi3 results in inhibition of BDNF-induced activation of Akt–mTORC1 and ERK pathways. shRNA-mediated down-regulation of Gαi1 and Gαi3 also affects dendritic outgrowth and formation of dendritic spines in the hippocampus. Specific behavioral studies performed by the Marshall team reveal that shRNA knockdown of Gαi1 and Gαi3 or complete DKO cause depression-like behaviors. Their studies suggest that downstream BDNF signaling via Gαi1 and Gαi3 is necessary not only for sustaining the well-being of neurons but also for normal antidepressive behaviors (11). So, how does neurotrophin signaling inside the cell specifically contribute to the regulation of mental functioning?
Neurotrophins, a unique family of polypeptide growth factors that include BDNF, regulate proliferation, proper differentiation, survival, and death of neuronal and nonneuronal cells. Neurotrophins act through downstream signaling cascades following receptor activation. Brain neurotrophins regulate early prenatal brain development and adult central nervous system plasticity (4). BDNF is the predominant neurotrophin in the brain (12). Synthesized as a precursor proBDNF, it is cleaved to release the mature, active form (11). Mature BDNF binds preferentially to the TrkB receptor, activating downstream signaling pathways such as mitogen-activated protein kinase (MAPK), phospholipase Cγ, and phosphatidylinositol-3 kinase pathway. These signaling cascades regulate transcription and dendritic translation of proteins required for neuronal survival, differentiation, and learning and memory formation in the hippocampus (13, 14).
Upon elimination of Gαi1 and Gαi3, Marshall et al. also observed decreased dendritic branching and reduced numbers of synaptic spines. Substantial loss of CA1 pyramidal neurons was observed in the Gαi1/Gαi3 DKO mouse, which was not found when Gαi1 and Gαi3 were depleted in adolescent brain using shRNA, although this latter model produced alterations in synaptic structure and the same behavioral deficits as the DKO. It is not clear whether loss of neurons in the DKO mouse hippocampus was caused by loss of developmental targeting of neurons or by enhanced cell death during neurogenesis or synaptogenesis. Whether longer overexpression of Gαi1/Gαi3 shRNA and/or a more challenging stress paradigm might also induce neuronal death remains to be answered, but it nevertheless seems clear that negative synaptic changes are sufficient to produce the depressive features.
Chronic stress substantially lowers BDNF (15). The insult chosen by Marshall et al. to cause depression in the animals, chronic mild stress, consists of 3 wk of sequential forced swim, restraint, water and food deprivation, housing in wet sawdust, light/dark cycle reversal, and housing in constant illumination or darkness (16, 17). In normal rodents, BDNF mRNA levels increase during early postnatal days in cortex, hippocampus, and cerebellum, correlating with the peak of postnatal synaptogenesis (18). BDNF is also required in adulthood for proper brain functioning, supporting neuronal network strengthening and plasticity. Although most BDNF homozygous knockout mice die in the first 2 postnatal days, some survive for 2–4 wk (19). These surviving mice nevertheless show severe impairments in growth and in movement coordination, and have reduced numbers of cranial and spinal sensory neurons, albeit with no gross structural abnormalities of the hippocampus (19, 20). They do, however, show impaired hippocampal long-term potentiation (LTP) and reduced numbers of presynaptic vesicles docked at presynaptic active zones (21), suggesting dysfunctional synapses. Apart from BDNF binding to the TrkB receptor, the precleaved form of BDNF, proBDNF, can act as a signaling molecule in the opposite manner to mature BDNF. ProBDNF binds specifically to the p75 neurotrophin receptor (p75NTR), a member of the tumor necrosis factor superfamily (22). Activation of p75NTR decreases the complexity of neuronal projections, triggers apoptosis, and facilitates hippocampal long-term depression, negatively affecting learning and memory formation (Fig. 1) (4, 23). Perhaps the structural changes in the Gαi1- and Gαi3-depleted and the DKO mice, including loss of pyramidal neurons in the hippocampus, might be partially attributed to the actions of proBDNF; the observed synaptic deficiencies even in the absence of cell death might be related to apoptotic signaling in the synapses alone (24, 25).
Fig. 1.
BDNF binding to TrkB receptor activates signaling cascades responsible for neuronal survival and synaptic plasticity. ProBDNF binds p75NTR and triggers long-term depression and apoptosis. Upon stress, including high-frequency synaptic stimulation, Bcl-2 is recruited to mitochondria to decrease the production of reactive oxygen species (ROS) and enhance effective ATP production; this supports relevant gene transcription and protein translation. Mild acute stress or high frequency synaptic activity recruit and may require BDNF signaling during learning and memory formation and for antidepressant coping strategies.
Stress also regulates intracellular signaling apart from its specific effects on BDNF (Fig. 1). Interestingly, brief stress-induced release of glucocorticoids, at low doses, supports neuronal branching and survival and positively influences performance in spatial learning and memory tasks (26, 27), implicating beneficial changes in limbic system networks. Under these conditions, corticosterone improves mitochondrial membrane potential and oxidation. The glucocorticoid receptor binds to the antiapoptotic B-cell lymphoma 2 protein (Bcl-2). This complex translocates into mitochondria to reduce the production of damaging reactive oxygen species (ROS) and prevent the opening of the prodeath permeability transition pore (28) while enhancing the supply of ATP required for proper brain function. The regulation of mitochondrial ATP production by low-dose corticosteroids may thereby shape the proper response of neurons to external stress. In contrast, high levels or chronic stress produce the opposite effects on mitochondria, depolarizing them and predisposing to activation of apoptotic mechanisms (28).
Neuronal excitability and synaptic plasticity require high mitochondrial fidelity (29, 30). Energy-dependent activities include calcium clearance in a timely manner, rapid actin cytoskeletal rearrangements, trafficking of synaptic vesicles, resetting of ion gradients after action potential firing, and new protein phosphorylation in response to synaptic stimulation (31). These events, crucial for neuroplasticity, are regulated by the timing and availability of mitochondrial energy supply. In cultured hippocampal neurons, BDNF treatment causes accumulation of mitochondria at presynaptic sites (32) where mitochondria contribute to synaptic vesicle docking and reserve pool galvanization (33–35). Specific phosphorylation events may relate to mitochondrial ATP production during hippocampal synaptic plasticity downstream of NMDA receptor stimulation. For example, phosphorylation of eukaryotic elongation factor 2 (eEF2) within the first few minutes after stimulation results in decreased overall protein synthesis (36), followed by exquisitely timed eEF2 dephosphorylation and increased translation of specific synaptic proteins. In summary (Fig. 1), the high-frequency stimulation that produces LTP is a stress to neurons and mitochondria that is alleviated by intracellular events that produce synaptic strengthening. Analogously, gene transcription and translation of specific proteins in response to synaptic activity in the limbic system may be necessary for the proper response to stress to prevent depression and enhance positive cognitive coping strategies. Loss of activation of growth factor-supported signaling pathways contributes to faulty responses to neuronal activity and stress.
Footnotes
The authors declare no conflict of interest.
See companion article on page E3549.
References
- 1.Otte C, et al. Major depressive disorder. Nat Rev Dis Primers. 2016;2:16065. doi: 10.1038/nrdp.2016.65. [DOI] [PubMed] [Google Scholar]
- 2.Kristensen P, Weisæth L, Heir T. Bereavement and mental health after sudden and violent losses: A review. Psychiatry. 2012;75:76–97. doi: 10.1521/psyc.2012.75.1.76. [DOI] [PubMed] [Google Scholar]
- 3.Giacco D, Laxhman N, Priebe S. Prevalence of and risk factors for mental disorders in refugees. Semin Cell Dev Biol. November 26, 2017 doi: 10.1016/j.semcdb.2017.11.030. [DOI] [PubMed] [Google Scholar]
- 4.Vicario-Abejón C, Owens D, McKay R, Segal M. Role of neurotrophins in central synapse formation and stabilization. Nat Rev Neurosci. 2002;3:965–974. doi: 10.1038/nrn988. [DOI] [PubMed] [Google Scholar]
- 5.Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995;15:1768–1777. doi: 10.1523/JNEUROSCI.15-03-01768.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Licznerski P, Duman RS. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression. Neuroscience. 2013;251:33–50. doi: 10.1016/j.neuroscience.2012.09.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus. 2006;16:239–249. doi: 10.1002/hipo.20156. [DOI] [PubMed] [Google Scholar]
- 8.Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15:7539–7547. doi: 10.1523/JNEUROSCI.15-11-07539.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Marshall J, et al. Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus. Proc Natl Acad Sci USA. 2018;115:E3549–E3558. doi: 10.1073/pnas.1722493115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hurowitz EH, et al. Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes. DNA Res. 2000;7:111–120. doi: 10.1093/dnares/7.2.111. [DOI] [PubMed] [Google Scholar]
- 11.Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev. 2012;64:238–258. doi: 10.1124/pr.111.005108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pezet S, Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets. 2004;8:391–399. doi: 10.1517/14728222.8.5.391. [DOI] [PubMed] [Google Scholar]
- 13.Leal G, Bramham CR, Duarte CB. BDNF and hippocampal synaptic plasticity. Vitam Horm. 2017;104:153–195. doi: 10.1016/bs.vh.2016.10.004. [DOI] [PubMed] [Google Scholar]
- 14.Leal G, et al. The RNA-binding protein hnRNP K mediates the effect of BDNF on dendritic mRNA metabolism and regulates synaptic NMDA receptors in hippocampal neurons. eNeuro. 2017;4:ENEURO.0268-17.2017. doi: 10.1523/ENEURO.0268-17.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Phillips C. Brain-derived neurotrophic factor, depression, and physical activity: Making the neuroplastic connection. Neural Plast. 2017;2017:7260130. doi: 10.1155/2017/7260130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zhou QG, et al. Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor. J Neurosci. 2011;31:7579–7590. doi: 10.1523/JNEUROSCI.0004-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hare BD, Ghosal S, Duman RS. Rapid acting antidepressants in chronic stress models: Molecular and cellular mechanisms. Chronic Stress (Thousand Oaks) 2017;1:10.1177/2470547017697317. doi: 10.1177/2470547017697317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.McAllister AK, Katz LC, Lo DC. Neurotrophins and synaptic plasticity. Annu Rev Neurosci. 1999;22:295–318. doi: 10.1146/annurev.neuro.22.1.295. [DOI] [PubMed] [Google Scholar]
- 19.Jones KR, Fariñas I, Backus C, Reichardt LF. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 1994;76:989–999. doi: 10.1016/0092-8674(94)90377-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ernfors P, Lee KF, Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature. 1994;368:147–150. doi: 10.1038/368147a0. [DOI] [PubMed] [Google Scholar]
- 21.Pozzo-Miller LD, et al. Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci. 1999;19:4972–4983. doi: 10.1523/JNEUROSCI.19-12-04972.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Chao MV. Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4:299–309. doi: 10.1038/nrn1078. [DOI] [PubMed] [Google Scholar]
- 23.Teng KK, Felice S, Kim T, Hempstead BL. Understanding proneurotrophin actions: Recent advances and challenges. Dev Neurobiol. 2010;70:350–359. doi: 10.1002/dneu.20768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Li Z, et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell. 2010;141:859–871. doi: 10.1016/j.cell.2010.03.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Jonas EA, et al. Proapoptotic N-truncated BCL-xL protein activates endogenous mitochondrial channels in living synaptic terminals. Proc Natl Acad Sci USA. 2004;101:13590–13595. doi: 10.1073/pnas.0401372101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Quirarte GL, Roozendaal B, McGaugh JL. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA. 1997;94:14048–14053. doi: 10.1073/pnas.94.25.14048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Gould E, Woolley CS, McEwen BS. Short-term glucocorticoid manipulations affect neuronal morphology and survival in the adult dentate gyrus. Neuroscience. 1990;37:367–375. doi: 10.1016/0306-4522(90)90407-u. [DOI] [PubMed] [Google Scholar]
- 28.Du J, et al. Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci USA. 2009;106:3543–3548. doi: 10.1073/pnas.0812671106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Zhou B, et al. Facilitation of axon regeneration by enhancing mitochondrial transport and rescuing energy deficits. J Cell Biol. 2016;214:103–119. doi: 10.1083/jcb.201605101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Jonas EA, Porter GA, Alavian KN. Bcl-xL in neuroprotection and plasticity. Front Physiol. 2014;5:355. doi: 10.3389/fphys.2014.00355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Jonas E. BCL-xL regulates synaptic plasticity. Mol Interv. 2006;6:208–222. doi: 10.1124/mi.6.4.7. [DOI] [PubMed] [Google Scholar]
- 32.Su B, Ji YS, Sun XL, Liu XH, Chen ZY. Brain-derived neurotrophic factor (BDNF)-induced mitochondrial motility arrest and presynaptic docking contribute to BDNF-enhanced synaptic transmission. J Biol Chem. 2014;289:1213–1226. doi: 10.1074/jbc.M113.526129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Verstreken P, et al. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron. 2005;47:365–378. doi: 10.1016/j.neuron.2005.06.018. [DOI] [PubMed] [Google Scholar]
- 34.Li H, et al. A Bcl-xL-Drp1 complex regulates synaptic vesicle membrane dynamics during endocytosis. Nat Cell Biol. 2013;15:773–785. doi: 10.1038/ncb2791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Courchet J, et al. Terminal axon branching is regulated by the LKB1-NUAK1 kinase pathway via presynaptic mitochondrial capture. Cell. 2013;153:1510–1525. doi: 10.1016/j.cell.2013.05.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Scheetz AJ, Nairn AC, Constantine-Paton M. NMDA receptor-mediated control of protein synthesis at developing synapses. Nat Neurosci. 2000;3:211–216. doi: 10.1038/72915. [DOI] [PubMed] [Google Scholar]

